Literature DB >> 18357770

The impact of CVB3 infection on host cell biology.

D Marchant1, X Si, H Luo, B McManus, D Yang.   

Abstract

CVB3 myocarditis can lead to dilated cardiomyopath (DCM). DCM is one of the leading causes of the need for heart transplantation, so it is important to understand the life cycle of CVB3 and its interactions with the host cell. Infection causes rapid death of host cardiomyocytes by altering normal cellular homeostasis for the efficient release of progeny virion. In this chapter, we will examine the impact that CVB3 replication has on host cell biology, from events that take place at receptor ligation to progeny virus release. The primary focus will be on the myriad of signalling pathways that are activated at all stages of virus replication and their downstream effects. We will also discuss some of the extracellular effects of infection as well as immune and matrixmetalloprotease activation. Interactions of host cell proteins with the 5' untranslated region (UTR) are required for translation and replication of CVB3. These interactions do not always benefit the virus since the interactions of a 28-kDa host protein with the 5' UTR are thought to be responsible for inhibitory activity against CVB3. Finally, we will discuss how the elucidation of the different stages of replication has provided the opportunity to develop novel strategies for combating CVB3 infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18357770     DOI: 10.1007/978-3-540-75546-3_8

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  13 in total

1.  Immunological and pathological consequences of coxsackievirus RNA persistence in the heart.

Authors:  Claudia T Flynn; Taishi Kimura; Kwesi Frimpong-Boateng; Stephanie Harkins; J Lindsay Whitton
Journal:  Virology       Date:  2017-12       Impact factor: 3.616

2.  Enhanced enteroviral infectivity via viral protease-mediated cleavage of Grb2-associated binder 1.

Authors:  Haoyu Deng; Gabriel Fung; Junyan Shi; Suowen Xu; Chen Wang; Meimei Yin; Jun Hou; Jingchun Zhang; Zheng-Gen Jin; Honglin Luo
Journal:  FASEB J       Date:  2015-07-16       Impact factor: 5.191

3.  Expression of an engineered soluble coxsackievirus and adenovirus receptor by a dimeric AAV9 vector inhibits adenovirus infection in mice.

Authors:  C Röger; T Pozzuto; R Klopfleisch; J Kurreck; S Pinkert; H Fechner
Journal:  Gene Ther       Date:  2015-03-19       Impact factor: 5.250

4.  Heterogeneous Nuclear Ribonucleoprotein M Facilitates Enterovirus Infection.

Authors:  Julienne M Jagdeo; Antoine Dufour; Gabriel Fung; Honglin Luo; Oded Kleifeld; Christopher M Overall; Eric Jan
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

Review 5.  Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Jay Reddy
Journal:  Int J Cardiol       Date:  2014-10-18       Impact factor: 4.164

6.  In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.

Authors:  Nadine Althof; Stephanie Harkins; Christopher C Kemball; Claudia T Flynn; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

7.  N-Terminomics TAILS Identifies Host Cell Substrates of Poliovirus and Coxsackievirus B3 3C Proteinases That Modulate Virus Infection.

Authors:  Julienne M Jagdeo; Antoine Dufour; Theo Klein; Nestor Solis; Oded Kleifeld; Jayachandran Kizhakkedathu; Honglin Luo; Christopher M Overall; Eric Jan
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

Review 8.  Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections.

Authors:  Henry Fechner; Sandra Pinkert; Anja Geisler; Wolfgang Poller; Jens Kurreck
Journal:  Molecules       Date:  2011-10-11       Impact factor: 4.411

9.  Attenuated strain of CVB3 with a mutation in the CAR-interacting region protects against both myocarditis and pancreatitis.

Authors:  Ninaad Lasrado; Arunakumar Gangaplara; Chandirasegaran Massilamany; Rajkumar Arumugam; Allison Shelbourn; Mahima T Rasquinha; Rakesh H Basavalingappa; Gustavo Delhon; Shi-Hua Xiang; Asit K Pattnaik; David Steffen; Jay Reddy
Journal:  Sci Rep       Date:  2021-06-14       Impact factor: 4.379

10.  Coxsackievirus-induced miR-21 disrupts cardiomyocyte interactions via the downregulation of intercalated disk components.

Authors:  Xin Ye; Huifang Mary Zhang; Ye Qiu; Paul J Hanson; Maged Gomaa Hemida; Wei Wei; Pamela A Hoodless; Fanny Chu; Decheng Yang
Journal:  PLoS Pathog       Date:  2014-04-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.